Skip to content
Screener

Pfizer PFE Payments to Acquire Property, Plant, and Equipment

Payments to Acquire Property, Plant, and Equipment at other companies

Amgen logo
AmgenAMGN
$513M+39.0%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$16.08M+30.7%

Other financials

Income statement

See full
Revenue$15.0B+2.6%
Gross profit$10.9B+0.6%
Net income-$248.0M-109%
EPS (diluted)-$0.04-108%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$152.52B+9.1%
Enterprise value$215.19B+9.2%
P/E17.2×
P/S2.4×+0.2×

Profitability

See full
Gross margin73.2%+1.1pp
Net margin15.7%
FCF margin18%+8.8pp

Returns & leverage

See full
Return on equity10.6%
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: Pfizer’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 7:03 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000078003-26-000054
(MILLIONS)Three Months Ended / March 29,2026Three Months Ended / March 30,2025
Other changes in assets and liabilities, net of acquisitions and divestitures(1,732)(1,919)
Net cash provided by/(used in) operating activities2,6152,335
Investing Activities
Purchases of property, plant and equipment(436)(564)
Purchases of short-term investments(2,569)(2,823)
Proceeds from redemptions/sales of short-term investments4,5763,955
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less(792)(3,852)
Purchases of long-term investments(104)(134)

Item 1.

FAQ

What is Pfizer's payments to acquire property, plant, and equipment?
Pfizer (PFE) reported payments to acquire property, plant, and equipment of $436M in Q1 2026.
How has Pfizer's payments to acquire property, plant, and equipment changed year-over-year?
Pfizer's payments to acquire property, plant, and equipment decreased by 22.7% year-over-year, from $564M to $436M.
What is the long-term trend for Pfizer's payments to acquire property, plant, and equipment?
Over 4 years (2021 to 2025), Pfizer's payments to acquire property, plant, and equipment has grown at a -0.8% compound annual growth rate (CAGR), from $2.71B to $2.63B.

Ask your AI about Pfizer's payments to acquire property, plant, and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude